BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mallya K, Gautam SK, Aithal A, Batra SK, Jain M. Modeling pancreatic cancer in mice for experimental therapeutics. Biochim Biophys Acta Rev Cancer 2021;1876:188554. [PMID: 33945847 DOI: 10.1016/j.bbcan.2021.188554] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Pretta A, Lai E, Persano M, Donisi C, Pinna G, Cimbro E, Parrino A, Spanu D, Mariani S, Liscia N, Dubois M, Migliari M, Impera V, Saba G, Pusceddu V, Puzzoni M, Ziranu P, Scartozzi M. Uncovering key targets of success for immunotherapy in pancreatic cancer. Expert Opin Ther Targets 2021;:1-19. [PMID: 34806517 DOI: 10.1080/14728222.2021.2010044] [Reference Citation Analysis]
2 Wang H, Zheng Y, Sun Q, Zhang Z, Zhao M, Peng C, Shi S. Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies. J Nanobiotechnology 2021;19:322. [PMID: 34654430 DOI: 10.1186/s12951-021-01062-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wang S, Gao C, Zheng Y, Yi L, Lu J, Huang X, Cai J, Zhang P, Cui Y, Ke A. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01518-8] [Reference Citation Analysis]